CANCER TARGETED TECHNOLOGY LLC

From the company

Cancer Targeted Technology (CTT) is a biotechnology company commercializing innovative small molecules that bind pivotal enzyme targets in cancer. CTT has designed and patented a targeting scaffold that recognizes Prostate-Specific Membrane Antigen (PSMA), and its small molecule drugs bind irreversibly to PSMA and are rapidly internalized by PSMA-expressing tumor cells. CTT develops targeted agents that detect, stratify and treat early and advanced disease and monitor treatment efficacy.